描述
The Johns Hopkins University Textbook of Dyslipidemia Hardbound
Author(s):
Peter O Kwiterovich Jr., MD
ISBN-10: 0-7817-8265-1
ISBN-13: 978-0-7817-8265-4
Pub Date: 2010
Pages: 320
Illustrations: 75
Trim Size: 8.375 x 10.875
The first comprehensive text on dyslipidemia from a major academic institution, this book covers all aspects of dyslipidemia as it relates to human disease, including coronary artery disease, cerebrovascular disease, peripheral vascular disease, and pancreatitis. The material is presented in a clinician-friendly format and includes references for additional reading.
Reflecting current guidelines from the National Cholesterol Education Program, the book explains why, when, and how to treat dyslipidemia. Coverage includes dietary treatment, drug treatment, and recommendations for special populations such as patients with coronary heart disease, patients at high risk for coronary heart disease, patients with diabetes, women, older adults, young adults, and racial and ethnic groups.
Table Of Contents
SECTION I FUNDAMENTAL ASPECTS OF DYSLIPIDEMIA AND ATHEROSCLEROSIS
Chapter 1: Lipid, Apolipoprotein, and Lipoprotein Metabolism: Implications for the Diagnosis of Dyslipidemia
Chapter 2: Measurement of Lipids, Lipoproteins, and Apolipoproteins
Chapter 3: Pathogenesis of Atherosclerosis and the Unstable Plaque
Chapter 4: Pathophysiology and Vascular Biology of Atherosclerosis
Chapter 5: Clinical Trial Evidence for Treatment of Dyslipidemia in the Prevention of Cardiovascular Disease
Chapter 6: Use of Noninvasive Methods to Diagnose Cardiovascular Disease in Dyslipidemic Patients
SECTION II METABOLIC DISORDERS OF DYSLIPIDEMIA
Chapter 7: Disorders of Hypertriglyceridemia
Chapter 8: Disorders of LDL Metabolism
Chapter 9: Disorders of HDL Metabolism
SECTION III DYSLIPIDEMIA IN SPECIAL GROUPS
Chapter 10: Pathophysiology and Treatment of Dyslipidemia in Diabetes
Chapter 11: Dyslipidemia in Renal Disease
Chapter 12: Dyslipidemia in Children and Adolescents
Chapter 13: Dyslipidemia and Atherosclerosis in Women
Chapter 14: Dyslipidemia in the Elderly: Special Insights to Inform the Management Strategy
SECTION IV NONTRADITIONAL RISK FACTORS AND CARDIOVASCULAR DISEASE
Chapter 15: Clinical Utility of Inflammatory Markers
Chapter 16: ApoB and the Atherogenic ApoB Dyslipoproteinemias
Chapter 17: Other Nontraditional Risk Factors for Cardiovascular Disease
Chapter 18: Lipoprotein (A): A Pleotrophic Risk Factor for Cardiovascular Disease
SECTION V DIETARY AND PHARMACOLOGIC TREATMENT OF DYSLIPIDEMIA AND CARDIOVASCULAR DISEASE
Chapter 19: Dietary Treatment of Dyslipidemia
Chapter 20: Trans Fatty Acids, Dyslipidemia, and Cardiovascular Disease
Chapter 21: Fish Oils in the Treatment of Dyslipidemia and Cardiovascular Disease
Chapter 22: Effect of Exercise on Dyslipidemia
Chapter 23: Pharmacologic Treatment of Dyslipidemia and Cardiovascular Disease
Chapter 24: Therapeutic Options for Modifying Obesity and Cardiometabolic Risk Factors
商品評價
目前沒有評價。